Preserved Efficacy and Reduced Toxicity with Intermittent Linezolid Dosing in Combination with Bedaquiline and Pretomanid in a Murine Tuberculosis Model is a research paper published in Antimicrobial Agents and Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: R01-AI-111992
HHS | National Institutes of Health
Grant: U19-AI-142735
HHS | National Institutes of Health
Grant: K24-AI-50349
NIAID NIH HHS
Grant: F32 AI050349
NIAID NIH HHS
Grant: U19 AI142735
NIAID NIH HHS
Grant: K24 AI150349
NIAID NIH HHS
Grant: R01 AI111992
National Institutes of Health
Grant: 5U19AI142735-02
Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb.
National Institutes of Health
Grant: 5R01AI111992-04
Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance
Global Alliance for TB Drug Development
J&J | Janssen Pharmaceuticals
FWCI
0.44
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals